Missouri Attorney General Andrew Bailey is leading a lawsuit to restrict access to mifepristone, a common abortion medication ...

The agency posted documents this week that the drugmaker had requested the drug be placed on the FDA's "Demonstrable ...

A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making ...

Rhythm projects 2024 revenues of $580-$590 million but no profits, raising questions about long-term viability. Read more about IRTC stock and its challenges.

Health officials are investigating an E. coli outbreak linked to McDonald's Quarter Pounders in multiple states, the Centers ...

A coalition of doctors has launched a petition calling for medical professionals, leaders, associations and agencies across ...

Managing blood sugar levels is increasingly important in today’s health-conscious world. With rising rates of diabetes and ...

Infections were reported between Sept. 27 and Oct. 11, in Colorado, Iowa, Kansas, Missouri, Montana, Nebraska, Oregon, Utah, ...

The U.S. Food and Drug Administration has approved Vyalev (foscarbidopa and foslevodopa) for adults living with advan ...

Three attorneys general argue federal laws around mifepristone make it difficult for states to enforce abortion bans.

Tuesday's approval makes Abrysvo the first RSV vaccine indicated for adults younger than 50, the biopharmaceutical company said. Last year, it was approved for use by those 60 years and older, as well ...

Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a ...